Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pearlman

Showing results (51-60 of 90) with videos related to

Pageof 9
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 1999
Germline structure and differential utilization of Igha and Ighb VH10 genesE A Whitcomb, B B Haines, A P Parmelee, et al.
Journal of Clinical Pharmacology|August 11, 2023
Investigation of the Effect of Lasmiditan on the Pharmacokinetics of P-Glycoprotein and Breast Cancer Resistance Protein SubstratesDebra Luffer-Atlas, Darren Wilbraham, Maria M Posada, et al.
Advances in Therapy|April 23, 2020
Efficacy and Safety of Galcanezumab for the Preventive Treatment of Migraine: A Narrative ReviewVincent Martin, Karen Hamrick Samaan, Sheena Aurora, et al.
Nature Protocols|September 6, 2008
Semiautomated and rapid quantification of nucleic acid footprinting and structure mapping experimentsAlain Laederach, Rhiju Das, Quentin Vicens, et al.
Headache|December 6, 2005
Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trialPaul Winner, Eric M Pearlman, Stephen L Linder, et al.
International Journal of Impotence Research|September 14, 2012
Testosterone replacement therapy in the setting of prostate cancer treated with radiationA W Pastuszak, A M Pearlman, G Godoy, et al.
Advances in Therapy|February 5, 2021
Onset, Maintenance, and Cessation of Effect of Galcanezumab for Prevention of Migraine: A Narrative Review of Three Randomized Placebo-Controlled TrialsDulanji K Kuruppu, James M North, Amy J Kovacik, et al.
Advances in Therapy|May 5, 2021
Galcanezumab Provides Consistent Efficacy Throughout the Dosing Interval Among Patients with Episodic and Chronic Migraine: A Post Hoc AnalysisPatricia Pozo-Rosich, Karen H Samaan, Todd J Schwedt, et al.
Headache|October 16, 2020
Efficacy of Galcanezumab for Migraine Prevention in Patients With a Medical History of Anxiety and/or Depression: A Post Hoc Analysis of the Phase 3, Randomized, Double-Blind, Placebo-Controlled REGAIN, and Pooled EVOLVE-1 and EVOLVE-2 StudiesTodd A Smitherman, Gretchen E Tietjen, Kory Schuh, et al.
International Journal of Environmental Research and Public Health|December 11, 2019
Mercury Exposure, Fish Consumption, and Perceived Risk among Pregnant Women in Coastal FloridaAdam M Schaefer, Matthew Zoffer, Luke Yrastorza, et al.
Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 1999
Germline structure and differential utilization of Igha and Ighb VH10 genesE A Whitcomb, B B Haines, A P Parmelee, et al.
Journal of Clinical Pharmacology|August 11, 2023
Investigation of the Effect of Lasmiditan on the Pharmacokinetics of P-Glycoprotein and Breast Cancer Resistance Protein SubstratesDebra Luffer-Atlas, Darren Wilbraham, Maria M Posada, et al.
Advances in Therapy|April 23, 2020
Efficacy and Safety of Galcanezumab for the Preventive Treatment of Migraine: A Narrative ReviewVincent Martin, Karen Hamrick Samaan, Sheena Aurora, et al.
Nature Protocols|September 6, 2008
Semiautomated and rapid quantification of nucleic acid footprinting and structure mapping experimentsAlain Laederach, Rhiju Das, Quentin Vicens, et al.
Headache|December 6, 2005
Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trialPaul Winner, Eric M Pearlman, Stephen L Linder, et al.
International Journal of Impotence Research|September 14, 2012
Testosterone replacement therapy in the setting of prostate cancer treated with radiationA W Pastuszak, A M Pearlman, G Godoy, et al.
Advances in Therapy|February 5, 2021
Onset, Maintenance, and Cessation of Effect of Galcanezumab for Prevention of Migraine: A Narrative Review of Three Randomized Placebo-Controlled TrialsDulanji K Kuruppu, James M North, Amy J Kovacik, et al.
Advances in Therapy|May 5, 2021
Galcanezumab Provides Consistent Efficacy Throughout the Dosing Interval Among Patients with Episodic and Chronic Migraine: A Post Hoc AnalysisPatricia Pozo-Rosich, Karen H Samaan, Todd J Schwedt, et al.
Headache|October 16, 2020
Efficacy of Galcanezumab for Migraine Prevention in Patients With a Medical History of Anxiety and/or Depression: A Post Hoc Analysis of the Phase 3, Randomized, Double-Blind, Placebo-Controlled REGAIN, and Pooled EVOLVE-1 and EVOLVE-2 StudiesTodd A Smitherman, Gretchen E Tietjen, Kory Schuh, et al.
International Journal of Environmental Research and Public Health|December 11, 2019
Mercury Exposure, Fish Consumption, and Perceived Risk among Pregnant Women in Coastal FloridaAdam M Schaefer, Matthew Zoffer, Luke Yrastorza, et al.
Pageof 9